Stoke Therapeutics Stock Technical Analysis

STOK Stock  USD 7.74  0.55  6.63%   
As of the 26th of March, Stoke Therapeutics has the Risk Adjusted Performance of (0.09), variance of 22.54, and Coefficient Of Variation of (846.33). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stoke Therapeutics, as well as the relationship between them.

Stoke Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Stoke, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Stoke
  
Stoke Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Stoke Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
22.75Strong Buy10Odds
Stoke Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Stoke analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Stoke stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Stoke Therapeutics, talking to its executives and customers, or listening to Stoke conference calls.
Stoke Analyst Advice Details
Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Stoke Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Stoke Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Stoke Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Stoke Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Stoke Therapeutics Trend Analysis

Use this graph to draw trend lines for Stoke Therapeutics. You can use it to identify possible trend reversals for Stoke Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Stoke Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Stoke Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Stoke Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.05  , which may suggest that Stoke Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 99.56, which is the sum of squared deviations for the predicted Stoke Therapeutics price change compared to its average price change.

About Stoke Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Stoke Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Stoke Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Stoke Therapeutics price pattern first instead of the macroeconomic environment surrounding Stoke Therapeutics. By analyzing Stoke Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Stoke Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Stoke Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2024 2025 (projected)
Payables Turnover4.154.36
Days Of Inventory On Hand1.0K903.01

Stoke Therapeutics March 26, 2025 Technical Indicators

Most technical analysis of Stoke help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Stoke from various momentum indicators to cycle indicators. When you analyze Stoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stoke Therapeutics March 26, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Stoke stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Stoke Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stoke Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stoke Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Stoke Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.65)
Revenue Per Share
0.677
Quarterly Revenue Growth
7.071
Return On Assets
(0.25)
Return On Equity
(0.46)
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.